PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
+17.9%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$15.4B
AUM Growth
–
Cap. Flow
+$15.4B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
26.84%
Holding
317
New
317
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
+$768M |
| 2 |
Microsoft
MSFT
|
+$710M |
| 3 |
Meta Platforms (Facebook)
META
|
+$546M |
| 4 |
Amazon
AMZN
|
+$373M |
| 5 |
Advanced Micro Devices
AMD
|
+$354M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 38.38% |
| 2 | Healthcare | 19.7% |
| 3 | Financials | 14.71% |
| 4 | Communication Services | 12.81% |
| 5 | Consumer Discretionary | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
151
Avadel Pharmaceuticals
AVDL
$1.49B
| $20.2M | 0.12% |
+3,027,705
| New | +$20.2M |
|
152
Becton Dickinson
BDX
$54.9B
| $20.2M | 0.12% |
+82,609
| New | +$20.2M |
|
153
Cigna
CI
$80.3B
| $20.1M | 0.12% |
+96,529
| New | +$20.1M |
|
|
DCPH
154
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $20M | 0.12% |
+350,000
| New | +$20M |
|
155
Cerence
CRNC
$409M
| $19.8M | 0.12% |
+196,932
| New | +$19.8M |
|
156
Amgen
AMGN
$151B
| $19.8M | 0.12% |
+85,919
| New | +$19.8M |
|
157
Aflac
AFL
$56.9B
| $19.6M | 0.12% |
+440,000
| New | +$19.6M |
|
158
Intercontinental Exchange
ICE
$99.5B
| $19.3M | 0.12% |
+167,185
| New | +$19.3M |
|
159
IAC Inc
IAC
$2.92B
| $19.3M | 0.12% |
+186,367
| New | +$19.3M |
|
160
Alcon
ALC
$39.5B
| $19.2M | 0.12% |
+311,687
| New | +$19.2M |
|
161
Intuitive Surgical
ISRG
$168B
| $19M | 0.12% |
+69,693
| New | +$19M |
|
162
SS&C Technologies
SSNC
$21.7B
| $19M | 0.12% |
+261,094
| New | +$19M |
|
163
Agilent Technologies
A
$36.3B
| $18.6M | 0.11% |
+157,314
| New | +$18.6M |
|
164
Affiliated Managers Group
AMG
$6.57B
| $17.8M | 0.11% |
+175,483
| New | +$17.8M |
|
165
LiveRamp
RAMP
$1.81B
| $17.8M | 0.11% |
+243,208
| New | +$17.8M |
|
166
Celldex Therapeutics
CLDX
$1.52B
| $17.5M | 0.11% |
+1,000,000
| New | +$17.5M |
|
167
Mohawk Industries
MHK
$8.67B
| $17.5M | 0.11% |
+123,849
| New | +$17.5M |
|
168
JPMorgan Chase
JPM
$805B
| $17.2M | 0.1% |
+135,675
| New | +$17.2M |
|
|
NSTG
169
DELISTED
NanoString Technologies, Inc.
NSTG
| $16.7M | 0.1% |
+250,000
| New | +$16.7M |
|
170
Baxter International
BAX
$12.4B
| $16.5M | 0.1% |
+206,071
| New | +$16.5M |
|
171
MaxLinear
MXL
$1.38B
| $15.9M | 0.1% |
+417,277
| New | +$15.9M |
|
172
Sabre
SABR
$686M
| $15.7M | 0.1% |
+1,307,884
| New | +$15.7M |
|
173
United Rentals
URI
$62.4B
| $15.6M | 0.09% |
+67,354
| New | +$15.6M |
|
174
IQVIA
IQV
$31.9B
| $15.5M | 0.09% |
+86,406
| New | +$15.5M |
|
175
Black Diamond Therapeutics
BDTX
$174M
| $14.9M | 0.09% |
+465,000
| New | +$14.9M |
|